Tonix Pharmaceuticals Presents Phase 1 Formulation Development Data for TNX-601 CR in a Poster Presentation at CNS Summit 2021
Stock Information for Tonix Pharmaceuticals Holding Corp.
Loading
Please wait while we load your information from QuoteMedia.